Enabling quantitative screening in retinal organoids 3D automated reporter quantification technologyThe Company of Biologists Sep 4, 2017
The advent of stem cell-derived retinal organoids has brought forth unprecedented opportunities for developmental and physiological studies, while presenting new therapeutic promise for retinal degenerative diseases. From a translational perspective, organoid systems provide exciting new prospects for drug discovery, offering the possibility to perform compound screening in a 3-dimensional (3D) human tissue context that resembles the native histoarchitecture and cellular interactions. However, inherent variability issues and a general lack of robust quantitative technologies for analyzing organoids in large-scale pose severe limitations for their use in translational applications. To address this need, we have developed a screening platform that enables accurate quantification of fluorescent reporters in complex human iPSC-derived retinal organoids. This platform incorporates a fluorescence microplate reader that allows XYZ-dimensional detection and fine-tuned wavelength selection. We have established optimal parameters for fluorescent reporter signal detection, devised methods to compensate for organoid size variability, evaluated performance and sensitivity parameters, and validated this technology for functional applications.